GGrantIndex
Sort

82,697 grants matching vaccine development

Development of Long-acting Cocaine Hydrolase as a Treatment for Cocaine Abuse

$1,041,021
Chang-Guo Zhan · University Of Kentucky · UH2 · FY2015 · DA

Antibody-Based Protection Against Dengue Virus

$1,040,996
Michael S. Diamond · Washington University · R01 · FY2017 · AI

Pathogenesis Of Enteric Viral Hepatitis

$1,040,807
Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.

$1,040,761
David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2022 · CA

Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.

$1,040,761
David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA

Cytokines in AIDS and Cancer Immunotherapy

$1,040,624
George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Human Papillomavirus and Polyomavirus Associated Malignancies.

$1,040,514
Denise A. Galloway · Fred Hutchinson Cancer Research Center · R35 · FY2020 · CA

Molecular Pathogenesis of Neoplasia

$1,040,298
John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS

Malaria Vaccine Trials in Mali

$1,039,899
Christopher V. Plowe · University Of Maryland Baltimore · U19 · FY2008 · AI

Office of the Clinical Director Clinical Services Research

$1,039,670
Maryland Pao · National Institute Of Mental Health · ZIA · FY2022 · MH

Cervical Cancer Prevention Prebiotic Device

$1,039,382
Joanna Elizabeth Ellington · Glyciome, Llc · R44 · FY2025 · CA

Rationally designed platform for enhanced glycoconjugate vaccines

$1,039,366
Dennis L. Kasper · Harvard Medical School · U19 · FY2016 · AI

Novel Targets for Vaccine Therapy

$1,039,362
Claudia Palena · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells

$1,039,249
James Even Voss · Scripps Research Institute, The · R01 · FY2023 · AI

Intersubtype recombinants for polyvalent anti-HIV vaccine

$1,039,238
Yong Gao · Case Western Reserve University · R01 · FY2012 · AI

IND‐enabling development of MM‐008 IVR, an antibody-based nonhormonal contraceptive intravaginal ring

$1,039,122
Richard A Cone · Mucommune, Llc · R44 · FY2022 · HD

Enhanced collaboration between US NIH and WHO on biomedical research

$1,038,805
Hans Troedsson · World Health Organization · U01 · FY2016 · AI

Preclinical Evaluation of Envelope Immunogens Optimized to Elicit VRCOI-class An

$1,038,590
Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · U19 · FY2016 · AI

Clinical Research Support for the CCR

$1,038,274
Thomas A Misteli · Division Of Basic Sciences - Nci · ZID · FY2020 · CA

NCMHD-Research Center of Excellence at the University of Pittsburgh

$1,038,184
Stephen B. Thomas · University Of Pittsburgh At Pittsburgh · P60 · FY2009 · MD

University of California, San Diego Clinical Trial Unit

$1,038,179
Stephen A Spector · University Of California, San Diego · U01 · FY2007 · AI

Understanding antibody responses and defining correlates of protection for endemic and pandemic coronavirus strains

$1,037,822
Viviana A Simon · Icahn School Of Medicine At Mount Sinai · P01 · FY2024 · AI

Plasma-Generated Hydroxyl Radicals for Analysis of Three-Dimensional Structures in Protein Therapeutics

$1,037,792
Faraz Choudhury · Immuto Scientific, Inc. · R44 · FY2022 · GM

Using DNA/MVA/protein immunization of rhesus macaques to investigate how the background of the HIV-1 envelope and nature of the protein boost shape the genetic and functional antibody landscape.

$1,037,744
Cynthia Ann Derdeyn · Emory University · R01 · FY2020 · AI

Core--Project Coordination and Product Development

$1,037,718
Mark B. Feinberg · Emory University · U19 · FY2008 · AI